Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasitibant intra-articular dose-finding study in symptomatic knee osteoarthritis
2013-004999-35Phase 2Completed
- Sponsor
- Menarini Group
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fasitibant in knee osteoarthritis (OA) (4 arms), sponsored by Menarini Group. Primary endpoint: Change in WOMAC VA 3.1 A total pain subscore from baseline over 2 weeks after randomization. Started Jan 2014; status: completed.
02
Drugs
fasitibant
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2013-004999-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004999-35.